DT Cloud Star Acquisition Corp (DTSQ) · Oct 7, 2026 · Other events
12-month extension — Deadline extended to October 26, 2027; $0.033 per remaining public share monthly
DT Cloud Star’s shareholder vote extends the SPAC’s business-combination deadline to October 2027, preserving time to close the PrimeGen transaction.
DTSQ is a pre-close SPAC trying to complete its announced PrimeGen biotech merger. The February 2026 transaction remains subject to regulatory and shareholder approvals, and the latest quarterly filing said it had not yet closed.
The filing buys the deal another year, but does not advance it. Shareholders approved extending the business-combination deadline from October 26, 2026 to October 26, 2027, in monthly increments, with a $0.033 payment into the trust account for each remaining public share per month. The amendment says shareholders approved the right to extend the deadline from October 26, 2026 to October 26, 2027. 〔0〕 (Trust Amendment)
Versus expectations, this is confirmation rather than new information. The extension was already put to shareholders in a scheduled meeting, so the vote removes the near-term liquidation deadline but adds no new PrimeGen economics, financing, regulatory milestone, or closing certainty. It preserves optionality for the merger while placing the extension payments on the sponsor or its affiliates. 〔1〕 (Trust Amendment)
Bottom line: DTSQ has more time to complete the PrimeGen transaction, but this is a procedural runway extension—not evidence that the merger itself is closer to closing. નજી
PrimeGen business combination closing
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!